Quantitative Systematic Strategies LLC Genmab A/S Transaction History

Quantitative Systematic Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$30.92 - $44.4 $456,100 - $654,944	-14,751 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$33.66 - $40.76 $395,269 - $478,644	-11,743 Reduced 44.32%	14,751 $600,000
Q3 2020 Nov 09, 2020	BUY	$33.07 - $38.68 $49,737 - $58,174	1,504 Added 6.02%	26,494 $970,000
Q2 2020 Aug 04, 2020	BUY	$20.05 - $33.89 $501,049 - $846,911	24,990 New	24,990 $847,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.